EGEN

Ukraine
Brusnytsia, Chernivtsi, Ukraine, 35806

Company profile

EGEN company profile

EGEN, Inc., is an Alabama-based specialty biopharmaceutical company developing safe and efficient delivery systems to be used to create products for treatment of human diseases. Their synthetic biocompatible delivery vehicles can be used to deliver therapeutic genes, inhibitory RNA (siRNA & shRNA) and small molecules. The delivery systems function by protecting the therapeutic cargo from degradation, promoting uptake by the target cells and facilitating intracellular trafficking.

Business identity

Contact email
[email protected]
Phone number
2565120077
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$1M-$10M
Founded
2002-01-01, Year

Headquarters

Postal code
35806
Country code
UA
Continent
Europe

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
3
Total equity funding
$23.4M
Last funding
Series Unknown / $3.9M / 2013-10-25
Last equity funding
Series Unknown / $3.9M
Articles
10
Exited on
2014-06-10

Founders and investors

No public relation records are available.